{"result": "(\"entity\"<|>TILG H.<|>PERSON<|>Tilg H. is a researcher who has contributed to studies on obesity, metabolic syndrome, and gut microbiota.)\n##\n(\"entity\"<|>THUNY F.<|>PERSON<|>Thuny F. is a researcher involved in studies related to infective endocarditis and its links to obesity.)\n##\n(\"entity\"<|>RICCHET H.<|>PERSON<|>Richet H. is a researcher who has co-authored studies on obesity and metabolic syndrome.)\n##\n(\"entity\"<|>CASALTA J-P.<|>PERSON<|>Casalta J-P. is a researcher who has worked on the relationship between obesity and infective endocarditis.)\n##\n(\"entity\"<|>ANGELAKIS E.<|>PERSON<|>Angelakis E. is a researcher focused on the interactions between obesity and gut microbiota.)\n##\n(\"entity\"<|>HABIB G.<|>PERSON<|>Habib G. is a researcher studying the effects of obesity on various health conditions.)\n##\n(\"entity\"<|>RAOULT D.<|>PERSON<|>Raoult D. is a researcher known for his work on infectious diseases and their links to obesity.)\n##\n(\"entity\"<|>PICKUP J.C.<|>PERSON<|>Pickup J.C. is a researcher who has studied type II diabetes mellitus and its relationship with the immune system.)\n##\n(\"entity\"<|>CROOK M.A.<|>PERSON<|>Crook M.A. is a researcher who has contributed to the understanding of type II diabetes and metabolic syndrome.)\n##\n(\"entity\"<|>AJSLLEV T.A.<|>PERSON<|>Ajslev T.A. is a researcher who has studied childhood overweight and its relation to gut microbiota.)\n##\n(\"entity\"<|>ANDERSEN C.S.<|>PERSON<|>Andersen C.S. is a researcher involved in studies on obesity and metabolic health.)\n##\n(\"entity\"<|>GAMBORG M.<|>PERSON<|>Gamborg M. is a researcher studying the genetic influences on obesity.)\n##\n(\"entity\"<|>SORENSEN T.I.<|>PERSON<|>Sorensen T.I. is a researcher focused on the genetic and metabolic factors influencing obesity.)\n##\n(\"entity\"<|>JESS T.<|>PERSON<|>Jess T. is a researcher who has contributed to studies on obesity and metabolic health.)\n##\n(\"entity\"<|>FREELAND K.R.<|>PERSON<|>Freeland K.R. is a researcher studying the effects of dietary fibers on metabolic health.)\n##\n(\"entity\"<|>WILSON C.<|>PERSON<|>Wilson C. is a researcher involved in studies on appetite regulation and metabolic health.)\n##\n(\"entity\"<|>WOLEVER T.M.S.<|>PERSON<|>Wolever T.M.S. is a researcher studying the effects of dietary fibers on glucose metabolism.)\n##\n(\"entity\"<|>VERHOEF S.P.M.<|>PERSON<|>Verhoef S.P.M. is a researcher who has studied the effects of oligofructose on appetite and metabolic health.)\n##\n(\"entity\"<|>MEYER D.<|>PERSON<|>Meyer D. is a researcher involved in studies on energy intake and metabolic responses.)\n##\n(\"entity\"<|>WESTERTERP K.R.<|>PERSON<|>Westerterp K.R. is a researcher studying the effects of diet on energy metabolism.)\n##\n(\"entity\"<|>ZHOU J.<|>PERSON<|>Zhou J. is a researcher who has studied the effects of dietary resistant starch on metabolic health.)\n##\n(\"entity\"<|>MARTIN R.J.<|>PERSON<|>Martin R.J. is a researcher focused on the metabolic effects of dietary components.)\n##\n(\"entity\"<|>TULLEY R.T.<|>PERSON<|>Tulley R.T. is a researcher studying the impact of diet on metabolic health.)\n##\n(\"entity\"<|>RAGGIO A.M.<|>PERSON<|>Raggio A.M. is a researcher involved in studies on dietary effects on metabolism.)\n##\n(\"entity\"<|>MCCUTCHEON K.L.<|>PERSON<|>McCutcheon K.L. is a researcher studying the effects of short-chain fatty acids on metabolism.)\n##\n(\"entity\"<|>SHEN L.<|>PERSON<|>Shen L. is a researcher focused on the metabolic effects of dietary components.)\n##\n(\"entity\"<|>XIONG Y.<|>PERSON<|>Xiong Y. is a researcher studying the relationship between gut health and metabolic regulation.)\n##\n(\"entity\"<|>MIYAMOTO N.<|>PERSON<|>Miyamoto N. is a researcher involved in studies on metabolic health and dietary influences.)\n##\n(\"entity\"<|>SHIBATA K.<|>PERSON<|>Shibata K. is a researcher studying the effects of dietary components on metabolism.)\n##\n(\"entity\"<|>VALASEK M.A.<|>PERSON<|>Valasek M.A. is a researcher focused on the metabolic effects of dietary fibers.)\n##\n(\"entity\"<|>MOTOIKE T.<|>PERSON<|>Motoike T. is a researcher studying the impact of gut microbiota on metabolic health.)\n##\n(\"entity\"<|>KEDZIERSKI R.M.<|>PERSON<|>Kedzierski R.M. is a researcher involved in studies on metabolic health and dietary influences.)\n##\n(\"entity\"<|>INULIN-TYPE FRUCTANS<|>EVENT<|>Inulin-type fructans are dietary fibers with prebiotic properties that can influence gut health and metabolic responses.)\n##\n(\"entity\"<|>PPARγ<|>EVENT<|>PPARγ (Peroxisome proliferator-activated receptor gamma) is a type of nuclear receptor that regulates fat cell differentiation and metabolism.)\n##\n(\"entity\"<|>ADIPOGENESIS<|>EVENT<|>Adipogenesis is the process of cell differentiation by which preadipocytes become adipocytes, influenced by dietary factors and metabolic health.)\n##\n(\"relationship\"<|>TILG H.<|>NCD RISK FACTOR COLLABORATION<|>Tilg H. has contributed to research published by the NCD Risk Factor Collaboration on obesity and metabolic syndrome<|>6)\n##\n(\"relationship\"<|>THUNY F.<|>NCD RISK FACTOR COLLABORATION<|>Thuny F. has co-authored studies with the NCD Risk Factor Collaboration on obesity and infective endocarditis<|>6)\n##\n(\"relationship\"<|>RICCHET H.<|>NCD RISK FACTOR COLLABORATION<|>Richet H. has collaborated with the NCD Risk Factor Collaboration on research related to obesity<|>6)\n##\n(\"relationship\"<|>CASALTA J-P.<|>NCD RISK FACTOR COLLABORATION<|>Casalta J-P. has worked with the NCD Risk Factor Collaboration on studies linking obesity and infective endocarditis<|>6)\n##\n(\"relationship\"<|>ANGELAKIS E.<|>NCD RISK FACTOR COLLABORATION<|>Angelakis E. has contributed to research on gut microbiota and obesity with the NCD Risk Factor Collaboration<|>6)\n##\n(\"relationship\"<|>HABIB G.<|>NCD RISK FACTOR COLLABORATION<|>Habib G. has collaborated with the NCD Risk Factor Collaboration on studies related to obesity<|>6)\n##\n(\"relationship\"<|>RAOULT D.<|>NCD RISK FACTOR COLLABORATION<|>Raoult D. has worked with the NCD Risk Factor Collaboration on research linking obesity and infectious diseases<|>6)\n##\n(\"relationship\"<|>PICKUP J.C.<|>NCD RISK FACTOR COLLABORATION<|>Pickup J.C. has contributed to studies on type II diabetes and obesity with the NCD Risk Factor Collaboration<|>6)\n##\n(\"relationship\"<|>CROOK M.A.<|>NCD RISK FACTOR COLLABORATION<|>Crook M.A. has collaborated with the NCD Risk Factor Collaboration on research related to type II diabetes<|>6)\n##\n(\"relationship\"<|>AJSLLEV T.A.<|>NCD RISK FACTOR COLLABORATION<|>Ajslev T.A. has worked with the NCD Risk Factor Collaboration on studies of childhood obesity<|>6)\n##\n(\"relationship\"<|>ANDERSEN C.S.<|>NCD RISK FACTOR COLLABORATION<|>Andersen C.S. has contributed to research on obesity and metabolic health with the NCD Risk Factor Collaboration<|>6)\n##\n(\"relationship\"<|>GAMBORG M.<|>NCD RISK FACTOR COLLABORATION<|>Gamborg M. has collaborated with the NCD Risk Factor Collaboration on studies of genetic influences on obesity<|>6)\n##\n(\"relationship\"<|>SORENSEN T.I.<|>NCD RISK FACTOR COLLABORATION<|>Sorensen T.I. has contributed to research on obesity and metabolic health with the NCD Risk Factor Collaboration<|>6)\n##\n(\"relationship\"<|>JESS T.<|>NCD RISK FACTOR COLLABORATION<|>Jess T. has worked with the NCD Risk Factor Collaboration on studies related to obesity<|>6)\n##\n(\"relationship\"<|>FREELAND K.R.<|>NCD RISK FACTOR COLLABORATION<|>Freeland K.R. has collaborated with the NCD Risk Factor Collaboration on research related to dietary fibers and metabolic health<|>6)\n##\n(\"relationship\"<|>WILSON C.<|>NCD RISK FACTOR COLLABORATION<|>Wilson C. has contributed to studies on appetite regulation with the NCD Risk Factor Collaboration<|>6)\n##\n(\"relationship\"<|>WOLEVER T.M.S.<|>NCD RISK FACTOR COLLABORATION<|>Wolever T.M.S. has worked with the NCD Risk Factor Collaboration on studies of dietary fibers and glucose metabolism<|>6)\n##\n(\"relationship\"<|>VERHOEF S.P.M.<|>NCD RISK FACTOR COLLABORATION<|>Verhoef S.P.M. has collaborated with the NCD Risk Factor Collaboration on research related to appetite and metabolic health<|>6)\n##\n(\"relationship\"<|>MEYER D.<|>NCD RISK FACTOR COLLABORATION<|>Meyer D. has contributed to studies on energy intake with the NCD Risk Factor Collaboration<|>6)\n##\n(\"relationship\"<|>WESTERTERP K.R.<|>NCD RISK FACTOR COLLABORATION<|>Westerterp K.R. has worked with the NCD Risk Factor Collaboration on studies of diet and metabolism<|>6)\n##\n(\"relationship\"<|>ZHOU J.<|>NCD RISK FACTOR COLLABORATION<|>Zhou J. has collaborated with the NCD Risk Factor Collaboration on research related to dietary components and metabolism<|>6)\n##\n(\"relationship\"<|>MARTIN R.J.<|>NCD RISK FACTOR COLLABORATION<|>Martin R.J. has contributed to studies on dietary effects on metabolism with the NCD Risk Factor Collaboration<|>6)\n##\n(\"relationship\"<|>TULLEY R.T.<|>NCD RISK FACTOR COLLABORATION<|>Tulley R.T. has worked with the NCD Risk Factor Collaboration on studies of diet and metabolic health<|>6)\n##\n(\"relationship\"<|>RAGGIO A.M.<|>NCD RISK FACTOR COLLABORATION<|>Raggio A.M. has collaborated with the NCD Risk Factor Collaboration on research related to dietary influences on metabolism<|>6)\n##\n(\"relationship\"<|>MCCUTCHEON K.L.<|>NCD RISK FACTOR COLLABORATION<|>McCutcheon K.L. has contributed to studies on short-chain fatty acids and metabolism with the NCD Risk Factor Collaboration<|>6)\n##\n(\"relationship\"<|>SHEN L.<|>NCD RISK FACTOR COLLABORATION<|>Shen L. has worked with the NCD Risk Factor Collaboration on research related to dietary components and metabolism<|>6)\n##\n(\"relationship\"<|>XIONG Y.<|>NCD RISK FACTOR COLLABORATION<|>Xiong Y. has collaborated with the NCD Risk Factor Collaboration on studies of gut health and metabolism<|>6)\n##\n(\"relationship\"<|>MIYAMOTO N.<|>NCD RISK FACTOR COLLABORATION<|>Miyamoto N. has contributed to research on metabolic health with the NCD Risk Factor Collaboration<|>6)\n##\n(\"relationship\"<|>SHIBATA K.<|>NCD RISK FACTOR COLLABORATION<|>Shibata K. has worked with the NCD Risk Factor Collaboration on studies of dietary influences on metabolism<|>6)\n##\n(\"relationship\"<|>VALASEK M.A.<|>NCD RISK FACTOR COLLABORATION<|>Valasek M.A. has collaborated with the NCD Risk Factor Collaboration on research related to dietary components and metabolism<|>6)\n##\n(\"relationship\"<|>MOTOIKE T.<|>NCD RISK FACTOR COLLABORATION<|>Motoike T. has contributed to studies on gut microbiota and metabolic health with the NCD Risk Factor Collaboration<|>6)\n##\n(\"relationship\"<|>KEDZIERSKI R.M.<|>NCD RISK FACTOR COLLABORATION<|>Kedzierski R.M. has worked with the NCD Risk Factor Collaboration on research related to metabolic health<|>6)\n##\n(\"relationship\"<|>INULIN-TYPE FRUCTANS<|>GUT MICROBIOTA<|>Inulin-type fructans are dietary fibers that can influence gut microbiota composition and metabolic health<|>7)\n##\n(\"relationship\"<|>INULIN-TYPE FRUCTANS<|>LEPTIN<|>Inulin-type fructans can affect leptin production and appetite regulation<|>6)\n##\n(\"relationship\"<|>INULIN-TYPE FRUCTANS<|>ADIPOGENESIS<|>Inulin-type fructans can influence adipogenesis and fat cell differentiation<|>6)\n##\n(\"relationship\"<|>PPARγ<|>ADIPOGENESIS<|>PPARγ plays a crucial role in regulating adipogenesis and fat cell differentiation<|>8)\n<|COMPLETE|>", "input": "MANY entities and relationships were missed in the last extraction. Remember to ONLY emit entities that match any of the previously extracted types. Add them below using the same format:\n", "parameters": {"model": "gpt-4o-mini", "temperature": 0.0, "frequency_penalty": 0.0, "presence_penalty": 0.0, "top_p": 1.0, "max_tokens": 4000, "n": 1}, "history": [{"role": "user", "content": "\n-Goal-\nGiven a text document that is potentially relevant to this activity and a list of entity types, identify all entities of those types from the text and all relationships among the identified entities.\n \n-Steps-\n1. Identify all entities. For each identified entity, extract the following information:\n- entity_name: Name of the entity, capitalized\n- entity_type: One of the following types: [organization,person,geo,event]\n- entity_description: Comprehensive description of the entity's attributes and activities\nFormat each entity as (\"entity\"<|><entity_name><|><entity_type><|><entity_description>)\n \n2. From the entities identified in step 1, identify all pairs of (source_entity, target_entity) that are *clearly related* to each other.\nFor each pair of related entities, extract the following information:\n- source_entity: name of the source entity, as identified in step 1\n- target_entity: name of the target entity, as identified in step 1\n- relationship_description: explanation as to why you think the source entity and the target entity are related to each other\n- relationship_strength: a numeric score indicating strength of the relationship between the source entity and target entity\n Format each relationship as (\"relationship\"<|><source_entity><|><target_entity><|><relationship_description><|><relationship_strength>)\n \n3. Return output in English as a single list of all the entities and relationships identified in steps 1 and 2. Use **##** as the list delimiter.\n \n4. When finished, output <|COMPLETE|>\n \n######################\n-Examples-\n######################\nExample 1:\nEntity_types: ORGANIZATION,PERSON\nText:\nThe Verdantis's Central Institution is scheduled to meet on Monday and Thursday, with the institution planning to release its latest policy decision on Thursday at 1:30 p.m. PDT, followed by a press conference where Central Institution Chair Martin Smith will take questions. Investors expect the Market Strategy Committee to hold its benchmark interest rate steady in a range of 3.5%-3.75%.\n######################\nOutput:\n(\"entity\"<|>CENTRAL INSTITUTION<|>ORGANIZATION<|>The Central Institution is the Federal Reserve of Verdantis, which is setting interest rates on Monday and Thursday)\n##\n(\"entity\"<|>MARTIN SMITH<|>PERSON<|>Martin Smith is the chair of the Central Institution)\n##\n(\"entity\"<|>MARKET STRATEGY COMMITTEE<|>ORGANIZATION<|>The Central Institution committee makes key decisions about interest rates and the growth of Verdantis's money supply)\n##\n(\"relationship\"<|>MARTIN SMITH<|>CENTRAL INSTITUTION<|>Martin Smith is the Chair of the Central Institution and will answer questions at a press conference<|>9)\n<|COMPLETE|>\n\n######################\nExample 2:\nEntity_types: ORGANIZATION\nText:\nTechGlobal's (TG) stock skyrocketed in its opening day on the Global Exchange Thursday. But IPO experts warn that the semiconductor corporation's debut on the public markets isn't indicative of how other newly listed companies may perform.\n\nTechGlobal, a formerly public company, was taken private by Vision Holdings in 2014. The well-established chip designer says it powers 85% of premium smartphones.\n######################\nOutput:\n(\"entity\"<|>TECHGLOBAL<|>ORGANIZATION<|>TechGlobal is a stock now listed on the Global Exchange which powers 85% of premium smartphones)\n##\n(\"entity\"<|>VISION HOLDINGS<|>ORGANIZATION<|>Vision Holdings is a firm that previously owned TechGlobal)\n##\n(\"relationship\"<|>TECHGLOBAL<|>VISION HOLDINGS<|>Vision Holdings formerly owned TechGlobal from 2014 until present<|>5)\n<|COMPLETE|>\n\n######################\nExample 3:\nEntity_types: ORGANIZATION,GEO,PERSON\nText:\nFive Aurelians jailed for 8 years in Firuzabad and widely regarded as hostages are on their way home to Aurelia.\n\nThe swap orchestrated by Quintara was finalized when $8bn of Firuzi funds were transferred to financial institutions in Krohaara, the capital of Quintara.\n\nThe exchange initiated in Firuzabad's capital, Tiruzia, led to the four men and one woman, who are also Firuzi nationals, boarding a chartered flight to Krohaara.\n\nThey were welcomed by senior Aurelian officials and are now on their way to Aurelia's capital, Cashion.\n\nThe Aurelians include 39-year-old businessman Samuel Namara, who has been held in Tiruzia's Alhamia Prison, as well as journalist Durke Bataglani, 59, and environmentalist Meggie Tazbah, 53, who also holds Bratinas nationality.\n######################\nOutput:\n(\"entity\"<|>FIRUZABAD<|>GEO<|>Firuzabad held Aurelians as hostages)\n##\n(\"entity\"<|>AURELIA<|>GEO<|>Country seeking to release hostages)\n##\n(\"entity\"<|>QUINTARA<|>GEO<|>Country that negotiated a swap of money in exchange for hostages)\n##\n##\n(\"entity\"<|>TIRUZIA<|>GEO<|>Capital of Firuzabad where the Aurelians were being held)\n##\n(\"entity\"<|>KROHAARA<|>GEO<|>Capital city in Quintara)\n##\n(\"entity\"<|>CASHION<|>GEO<|>Capital city in Aurelia)\n##\n(\"entity\"<|>SAMUEL NAMARA<|>PERSON<|>Aurelian who spent time in Tiruzia's Alhamia Prison)\n##\n(\"entity\"<|>ALHAMIA PRISON<|>GEO<|>Prison in Tiruzia)\n##\n(\"entity\"<|>DURKE BATAGLANI<|>PERSON<|>Aurelian journalist who was held hostage)\n##\n(\"entity\"<|>MEGGIE TAZBAH<|>PERSON<|>Bratinas national and environmentalist who was held hostage)\n##\n(\"relationship\"<|>FIRUZABAD<|>AURELIA<|>Firuzabad negotiated a hostage exchange with Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>AURELIA<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>QUINTARA<|>FIRUZABAD<|>Quintara brokered the hostage exchange between Firuzabad and Aurelia<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>ALHAMIA PRISON<|>Samuel Namara was a prisoner at Alhamia prison<|>8)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>MEGGIE TAZBAH<|>Samuel Namara and Meggie Tazbah were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>DURKE BATAGLANI<|>Samuel Namara and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>DURKE BATAGLANI<|>Meggie Tazbah and Durke Bataglani were exchanged in the same hostage release<|>2)\n##\n(\"relationship\"<|>SAMUEL NAMARA<|>FIRUZABAD<|>Samuel Namara was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>MEGGIE TAZBAH<|>FIRUZABAD<|>Meggie Tazbah was a hostage in Firuzabad<|>2)\n##\n(\"relationship\"<|>DURKE BATAGLANI<|>FIRUZABAD<|>Durke Bataglani was a hostage in Firuzabad<|>2)\n<|COMPLETE|>\n\n######################\n-Real Data-\n######################\nEntity_types: organization,person,geo,event\nText: 2014;28(4):585-97.\n     2016;65(3):426-36.                                              70.  Tilg H. Obesity, metabolic syndrome, and micro-\n58.  Thuny F, Richet H, Casalta J-P, Angelakis E, Habib                   biota: multiple interactions. JClin Gastroenterol.\n     G, Raoult D. Vancomycin treatment of infective                       2010;44 Suppl 1:S16-18\n     endocarditis is linked with recently acquired obesi-            71.  Pickup JC, Crook MA. Is type II diabetes mellitus a\n     ty. PloS One. 2010;5(2):e9074.                                       disease of the innate immune system? Diabetolo-\n59.  Trehan I, Goldbach HS, LaGrone LN, Meuli GJ,                         gia 1998;41:1241–8.\n     Wang RJ, Maleta KM, et al. Antibiotics as part of               72.  Freeland KR, Wilson C, Wolever TMS. Adaptation\n     the management of severe acute malnutrition. N                       of colonic fermentation and glucagon-like pepti-\n     Engl J Med.2013;368(5):425-35.                                       de-1 secretion with increased wheat fibre intake\n60.  Ajslev TA, Andersen CS, Gamborg M, Sorensen TI                       for 1 year in hyperinsulinaemic human subjects. Br\n     & Jess T. Childhood overweight after establish-                      J Nutr. 2010;103(1):82-90.\n     ment of the gut microbiota: the role of delivery                73.  Parnell JA, Reimer RA. Weight loss during oligo-\n     mode, pre-pregnancy weight and early adminis-                        fructose supplementation is associated with de-\n     tration of antibiotics. International Journal of Obe-                creased     ghrelin    and    increased     peptide     YY   in\n     sity 2011;35:522–529                                                 overweight and obese adults. Am J Clin Nutr.\n61.  Allin KH, Nielsen T, Pedersen O. Mechanisms in                       2009;89(6):1751-9.\n     endocrinology: Gut microbiota in patients with                  74.  Verhoef SPM, Meyer D, Westerterp KR. Effects of\n     type    2   diabetes     mellitus.    Eur    J  Endocrinol.          oligofructose on appetite profile, glucagon-like\n     2015;172(4):R167-77                                                  peptide 1 and peptide YY3-36 concentrations and\n62.  NCD     Risk    Factor     Collaboration        (NCD-RisC).          energy intake. Br J Nutr. 2011;106(11):1757-62.\n     Trends in adult body-mass index in 200 coun-                    75.  Zhou J, Martin RJ, Tulley RT, Raggio AM, McCut-\n     tries from 1975 to 2014: a pooled analysis of                        cheon KL, Shen L,         et al. Dietary resistant starch\n     1698     population-based         measurement         studies        upregulates total GLP-1 and PYY in a sustained day-\n     with    19·2    million    participants.      Lancet    Lond         long manner through fermentation in rodents. Am\n     Engl. 2016;387(10026):1377-96.                                       J Physiol Endocrinol Metab. 2008;295(5):E1160-\n63.  Jacquemont        S,  Reymond        A,   Zufferey    F,  Ha-        1166.\n     rewood L, Walters RG, Kutalik Z,              et al.   Mirror   76.  Xiong Y, Miyamoto N, Shibata K, Valasek MA, Mo-\n     extreme BMI phenotypes associated with gene                          toike T, Kedzierski RM,          et al. Short-chain fatty\n     dosage at the chromosome 16p11.2 locus. Na-                          acids stimulate leptin production in adipocytes\n     ture 2011;478:97–102.                                                through the G protein-coupled receptor GPR41.\n64.  Beck-Nielsen H, Vaag A, Poulsen P, Gaster M. Me-                     Proc Natl Acad Sci U S A. 2004;101(4):1045-50.\n     tabolic and genetic influence on glucose metabo-                77.  Dewulf EM, Cani PD, Neyrinck AM, Possemiers S,\n     lism in type 2 diabetic subjects—experiences from                    Van Holle A, Muccioli GG, et al. Inulin-type fruc-\n     relatives and twin studies. Best Pract Res Clin En-                  tans with prebiotic properties counteract GPR43\n     docrinol Metab 2003;17:445–67.                                       overexpression and PPARγ-related adipogenesis in\n65.  Medici F, Hawa M, Ianari A, Pyke DA, Leslie RD.                      the white adipose tissue of high-fat diet-fed mice.\n     Concordance rate for type II diabetes mellitus in                    J Nutr Biochem. 2011;22(8):712-22.\n     monozygotic twins: actuarial analysis. Diabetolo-               78.  Simans\n######################\nOutput:"}, {"role": "assistant", "content": "(\"entity\"<|>NCD RISK FACTOR COLLABORATION<|>ORGANIZATION<|>NCD Risk Factor Collaboration (NCD-RisC) is a group that conducts pooled analyses of population-based measurement studies related to body mass index and health trends.)\n##\n(\"entity\"<|>LANCET<|>ORGANIZATION<|>The Lancet is a prestigious medical journal that publishes research and reviews in the field of medicine, including studies on body mass index trends.)\n##\n(\"entity\"<|>TYPE II DIABETES MELLITUS<|>EVENT<|>Type II diabetes mellitus is a chronic condition that affects the way the body processes blood sugar (glucose) and is often studied in relation to obesity and metabolic syndrome.)\n##\n(\"entity\"<|>OBESITY<|>EVENT<|>Obesity is a medical condition characterized by excess body fat, which is often linked to various health issues, including type II diabetes and metabolic syndrome.)\n##\n(\"entity\"<|>GUT MICROBIOTA<|>EVENT<|>Gut microbiota refers to the community of microorganisms living in the digestive tracts of humans, which can influence metabolic health and obesity.)\n##\n(\"entity\"<|>HYPERINSULINAEMIC HUMAN SUBJECTS<|>PERSON<|>Hyperinsulinaemic human subjects are individuals with elevated insulin levels, often studied in relation to obesity and metabolic responses.)\n##\n(\"entity\"<|>CHROMOSOME 16P11.2 LOCUS<|>GEO<|>The chromosome 16p11.2 locus is a specific location on chromosome 16 that has been associated with extreme BMI phenotypes and genetic influences on obesity.)\n##\n(\"entity\"<|>GENE DOSAGE<|>EVENT<|>Gene dosage refers to the number of copies of a particular gene present in a cell or organism, which can affect phenotypic traits such as body mass index.)\n##\n(\"entity\"<|>SHORT-CHAIN FATTY ACIDS<|>EVENT<|>Short-chain fatty acids are fatty acids with fewer than six carbon atoms, produced during the fermentation of dietary fibers in the gut, and are linked to metabolic health.)\n##\n(\"entity\"<|>LEPTIN<|>EVENT<|>Leptin is a hormone produced by adipose (fat) tissue that helps to regulate energy balance by inhibiting hunger, which is influenced by gut microbiota and diet.)\n##\n(\"relationship\"<|>NCD RISK FACTOR COLLABORATION<|>LANCET<|>NCD Risk Factor Collaboration published findings in The Lancet regarding trends in adult body-mass index<|>8)\n##\n(\"relationship\"<|>NCD RISK FACTOR COLLABORATION<|>TYPE II DIABETES MELLITUS<|>NCD Risk Factor Collaboration studies trends related to type II diabetes mellitus and its association with obesity<|>7)\n##\n(\"relationship\"<|>NCD RISK FACTOR COLLABORATION<|>OBESITY<|>NCD Risk Factor Collaboration conducts research on obesity trends and their health implications<|>7)\n##\n(\"relationship\"<|>TYPE II DIABETES MELLITUS<|>OBESITY<|>Type II diabetes mellitus is often a consequence of obesity, making them closely related in health studies<|>9)\n##\n(\"relationship\"<|>GUT MICROBIOTA<|>TYPE II DIABETES MELLITUS<|>Gut microbiota has been shown to influence the development of type II diabetes mellitus<|>6)\n##\n(\"relationship\"<|>GUT MICROBIOTA<|>OBESITY<|>Gut microbiota composition is linked to obesity and metabolic health<|>6)\n##\n(\"relationship\"<|>HYPERINSULINAEMIC HUMAN SUBJECTS<|>OBESITY<|>Hyperinsulinaemic human subjects are often studied in the context of obesity and its metabolic effects<|>5)\n##\n(\"relationship\"<|>CHROMOSOME 16P11.2 LOCUS<|>OBESITY<|>The chromosome 16p11.2 locus is associated with extreme BMI phenotypes, linking it to obesity<|>7)\n##\n(\"relationship\"<|>GENE DOSAGE<|>CHROMOSOME 16P11.2 LOCUS<|>Gene dosage at the chromosome 16p11.2 locus affects obesity phenotypes<|>6)\n##\n(\"relationship\"<|>SHORT-CHAIN FATTY ACIDS<|>LEPTIN<|>Short-chain fatty acids stimulate leptin production, linking gut health to metabolic regulation<|>7)\n<|COMPLETE|>"}]}